Section Arrow
EVAX.NASDAQ
- Evaxion A/S
Quotes are at least 15-min delayed:2026/04/26 18:55 EDT
Regular Hours
Last
 4.03
-0.22 (-5.18%)
Day High 
4.27 
Prev. Close
4.25 
1-M High
4.71 
Volume 
31.46K 
Bid
4.05
Ask
4.66
Day Low
3.98 
Open
4.27 
1-M Low
3.31 
Market Cap 
35.45M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.26 
20-SMA 4.03 
50-SMA 3.71 
52-W High 12.1499 
52-W Low 1.42 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.00/-0.69
Enterprise Value
42.40M
Balance Sheet
Book Value Per Share
2.04
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.53M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCNIScinai Immunotherapeutics Ltd.0.737+0.281+61.62%0.15PE
ENVBEnveric Biosciences Inc.5.04+1.02+25.37%0PE
SGMOSangamo Therapeutics0.1901-0.0649-25.45%-- 
LNAILunai Bioworks Inc.0.3101+0.0054+1.77%-- 
IBRXImmunityBio7.44-0.75-9.16%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.